期刊文献+

COX-2、CCR7表达与乳腺癌临床病理参数的关系 被引量:1

Correlation between the expressions of COX-2,CCR7 and clinicopathologic parameters in breast cancer
暂未订购
导出
摘要 目的探讨环氧合酶2(cyclooxygenase 2,COX-2)、C-C家族趋化因子受体7(C-C chemokine receptor 7,CCR7)表达与乳腺癌临床病理学参数的关系,并分析COX-2、CCR7表达的相关性。方法用免疫组织化学检测乳腺癌组织80例、乳腺癌癌旁组织15例中COX-2、CCR7的表达,分析其表达与临床病理学参数的关系,对COX-2、CCR7的表达进行相关性分析。结果在乳腺癌组织,COX-2、CCR7均高表达,表达率分别为42.5%和38.8%,两者表达有相关性(P<0.05)。COX-2、CCR7高表达均与肿瘤的病理分化、肿瘤大小、淋巴转移、TNM分期相关(P<0.05),与组织学分型、患者年龄无关。结论 COX-2、CCR7在乳腺癌组织高表达,两者表达有相关性,且与乳腺癌临床病理学参数有关。提示临床上联合检测COX-2和CCR7对乳腺癌转移的预测可能会有所帮助。 【Objective】 To assess the co-expression of COX-2 and CCR7 in human breast cancer and analyze their relationship and correlation with clinicopathologic parameters.【Methods】 COX-2 and CCR7 expressions in the tissue samples of primary tumors from 80 breast cancer patients and normal breast tissue samples from 15 breast cancer patients were examined by immunohistochemica assay.Then,their relationships and correlation with clinicopathologic parameters were analyzed.【Results】 COX-2 and CCR7 were over expression in breast cancer tissues,the positive rate of COX-2 and CCR7 in the primary tumor was 42.5% and 38.8%,respectively.A significant correlation was found between the expression scores of COX-2 and CCR7(P 0.05),and both also were correlated with lymph node metastasis,histology,primary tumor size and TNM stage(P 0.05),but both were not related to histology type and patients' age(P 0.05).【Conclusions】 The over expression of COX-2 and CCR7 in human breast cancer were correlated,and significantly associated with clinicopathologic parameters.The results indicate that COX-2 and CCR7 might be a co-marker of prediction the metastasis of breast cancer.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2011年第8期990-992,997,共4页 China Journal of Modern Medicine
关键词 乳腺癌 COX-2 CCR7 肿瘤转移 breast cancer COX-2 CCR7 clinicopathologic parameters
  • 相关文献

参考文献10

  • 1ZHU L, LOO WT, CHENG CW, et al. Possible predictive mark- ers related to micro-metastasis in breast cancer patients[J]. Oncol Rep, 2006, 15(5): 1217-23.
  • 2PARK K, HAN S, SHIN E, et al. Cox-2 expression on tissue microarray of breast cancer [J]. Eur J Surg Oncol, 2006, 32(10): 1093-1096.
  • 3MULLER A, HOMEY B, SOTO H, et al. Involvement of ehemokine receptors in breast cancer metastasis[J]. Nature, 2001, 410(6824): 24-25.
  • 4NESLIHAN CABIOGLU, M. SERTAC YAZICI, BANU ARUN, et al. CCR7 and CXCR4 as Novel Biomarkers Predicting Axillary Lymph Node Metastasis in T1Breast Cancer [J]. Clin Cancer Res 2005, 11(16): 5686-5693.
  • 5YU SY, ZHOU ZQ, PANG Q, et al. Correlation between the ex- pressions of Cox-2 and CCR7 and clinicopatholgical parameters of colorectal cancer[J]. Chinese Journal of General Surgery, 2007, 10: 1017-1018. Chinese.
  • 6KANAOKA S, TAKAI T, YOSHIDA K. Cyclooxygenase-2 and tumor biology[J]. Adv Clin Chem, 2007, 43: 59-78.
  • 7LIM SC. Role of COX-2, VEGF and cyclin D1 in mammary in- fdtrating duct carcinoma[J]. Oncol Rep, 2003, 10(5): 1241-1249.
  • 8SIVULA A, TALVENSAARI-MATTILA A, LUNDIN J, et al.Association of cyclooxygenase-2 and matrix metalloproteinase-2 expression in human breast cancer [J]. Breast Cancer Res Treat, 2005, 89(3): 215-220.
  • 9SINGH B, BERRY JA, SHOHER A, et al. COX-2 induces IL-11 production in human breast cancer cells [J]. J Surg Res, 2006, 131(2): 267-275.
  • 10KOCHETKOVA M, KUMAR S, MCCOLL SR. Chemokine re- ceptors CXCR4 and CCR7 promote metastasis by preventing anoikis in cancer cells [J]. Cell Death Differ, 2009, 16(5): 664-673.

同被引文献13

  • 1Kono M,Watanabe M,Abukawa H, etal. Cyclo-ox- ygenase-2 expression is associated with vascμlar en- dothelial growth factor C expression and lymph node metastasis in oral squamous cell carcinoma[J]. Oral Maxillofac Surg, 2013,71 (10) : 1694-1702.
  • 2Mrena J, Wiksten JP, Kokkola A , et al. COX-2 is associated with proliferation and apoptosis markers and serves as an independent prognostic factor in gastric cancer [J]. Tumor Biol,2010,3(1): 1-7.
  • 3Kirane A, Toombs JE, Larsen JE. et al. Epithelial- mesenchymal transition increases tumor sensitivity to COX-2 inhibition by apricoxib. [J]. Carcinogene- sis, 2012, 33(9) :1639-1646.
  • 4Lai TY, Chen LM,Lin JY, et al. 17b-Estradiol in- hibits prostaglandin E2-induced COX-2 expressions and cell migration by suppressing Akt and ERK1/2 signaling pathways in human LoVo colon cancer cells [J]. Mol Cell Biochem, 2010, 342 (1/2):63-70.
  • 5Dhakal HP, Naume B, Synnestvedt M,et al. Ex pression of cyclooxygenase-2 in invasive breast car cinomas and its prognostic impact[J]. Histol His topathol, 2012,27(10) :1315-1325.
  • 6Noguehi L,Takeno S,Shibata L, et al. VEGF-C ex- pression correlates with histologieal differentiation and metastasis in cell careingma of the squamous e- sophagus[J]. Oncol Rep,2002,9(5) :995-999.
  • 7Guo HF, Chen XC, Zhu J, et al. Expressions of COX-2 and VEGF-C in gastric cancer: correlations with lymphangiogenesis and prognostic implica- tions. [J] J Exp Clin Cancer Res, 2011,32 (30): 1037-1044.
  • 8石建华,刘纯伦,罗访,潘敏,徐晓萌.Darbufelone对胃癌SGC-7901细胞侵袭转移能力的影响[J].重庆医科大学学报,2010,35(7):1021-1025. 被引量:2
  • 9陈晓鹏,王东,王冠男,胡明华,张卫东,张国政,张帆.伊立替康联合亚甲蓝示踪进展期胃癌淋巴结的研究[J].中国临床药理学与治疗学,2011,16(7):792-796. 被引量:1
  • 10吴菲,林国桢,张晋昕.我国恶性肿瘤发病现状及趋势[J].中国肿瘤,2012,21(2):81-85. 被引量:380

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部